High-Dose DHA Reaches the Brain but Didn't Boost Memory in 2 Years
Graded Strong — randomised double-blind placebo-controlled trial in 365 older adults over 24 months, though dropout reached 38%, largely due to COVID-19, and all participants came from a single site.
- Design
- —
- Participants
- 365
- Duration
- —
- Funding
- One author reports grants from and consulting fees for many drug companies…
This study suggests high-dose DHA reaches the brain but may not improve memory in at-risk older adults.
Omega-3 DHA is a popular pick for brain health, especially for people at risk of dementia. This two-year trial gave older adults with low omega-3 intake high-dose DHA. The DHA clearly made it into their brain fluid, even in those carrying the high-risk APOE ε4 gene. But there was no difference in memory, thinking, or brain size compared to placebo.
Conflict of Interest Disclosure: One author reports grants from and consulting fees for many drug companies, including Eisai, Roche, and Novo Nordisk, outside this work.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
Related Studies
All researchThe Rare APOE2 Gene Protects the Brain by Keeping Blood Vessel Cells Clean
Most people know APOE4 as the gene that raises Alzheimer's risk.
Creatine and Dementia: Big Hype, Surprisingly Thin Human Evidence
Creatine is popular for muscle and increasingly for the brain, so researchers combed through everything published on creatine and dementia.
Vitamin D3 Plus DHA Beat Either Alone for Memory in Older Adults With MCI
Older adults with mild cognitive impairment took vitamin D3, DHA (an omega-3 fat), both, or a placebo for a year.
